The WACC of Nova Leap Health Corp (NLH.V) is 8.0%.
Range | Selected | |
Cost of equity | 6.7% - 10.8% | 8.75% |
Tax rate | 26.9% - 29.6% | 28.25% |
Cost of debt | 4.0% - 5.1% | 4.55% |
WACC | 6.2% - 9.8% | 8.0% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 5.1% | 6.1% |
Adjusted beta | 0.55 | 0.97 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 6.7% | 10.8% |
Tax rate | 26.9% | 29.6% |
Debt/Equity ratio | 0.15 | 0.15 |
Cost of debt | 4.0% | 5.1% |
After-tax WACC | 6.2% | 9.8% |
Selected WACC | 8.0% | |
Debt/Equity | Unlevered | |||
Peers | Company Name | ratio | Beta | beta |
NLH.V | Nova Leap Health Corp | 0.15 | 0 | 0 |
AIH | Aesthetic Medical International Holdings Group Ltd | 3.4 | 1.62 | 0.47 |
CCEL | Cryo-Cell International Inc | 0.22 | -0.14 | -0.12 |
CTHZ | Cancer Treatment Holdings Inc | 0.37 | 0.33 | 0.26 |
FCHS | First Choice Healthcare Solutions Inc | 134.3 | 0.68 | 0.01 |
IDXG | Interpace Biosciences Inc | 1.13 | 1.73 | 0.96 |
IOM.V | Assure Holdings Corp | 0.14 | 1.89 | 1.72 |
MBCN.TO | MindBeacon Holdings Inc | 0.02 | 0.91 | 0.9 |
NPTH.V | NeuPath Health Inc | 0.77 | 1.3 | 0.84 |
PMD | Psychemedics Corp | 0.02 | 1.03 | 1.02 |
Low | High | |
Unlevered beta | 0.39 | 0.86 |
Relevered beta | 0.33 | 0.96 |
Adjusted relevered beta | 0.55 | 0.97 |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for NLH.V:
cost_of_equity (8.75%) = risk_free_rate (4.15%) + equity_risk_premium (5.60%) * adjusted_beta (0.55) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.